Alexis Mitelpunkt
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Alexis Mitelpunkt has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Kang Jin
Cutaneous Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, USA
3 shared publications - Mira Marcus-Kalish
The Sagol School for Neurosciences, Tel Aviv University, Tel Aviv, Israel
3 shared publications - Netta Shachar
Department of Statistics and Operations Research, Tel Aviv University, Tel Aviv, Israel
3 shared publications - Tal Galili
Department of Statistics and Operations Research, Tel Aviv University, Tel Aviv 6997801, Israel
3 shared publications - Tal Kozlovski
Statistics and Operation Research, Tel Aviv University, Tel Aviv, Israel
3 shared publications - Yoav Benjamini
Tel Aviv University
3 shared publications
Latest Publications
- 1 December 2021
- Published by Elsevier in Pediatric Neurology
- Vol. 125, 1-8
Disordered Eating Behaviors in Young Individuals With Idiopathic Intracranial Hypertension
- 1 December 2021
- Published by Elsevier in Pediatric Neurology
- Vol. 125, 1-8
Disordered Eating Behaviors in Young Individuals With Idiopathic Intracranial Hypertension
- Open Access
- 2 November 2021
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-8
Prognostic value of neutrophil-to-lymphocyte ratio in COVID-19 compared with Influenza and respiratory syncytial virus infection
A high neutrophil to lymphocyte ratio (NLR) is considered an unfavorable prognostic factor in various diseases, including COVID-19. The prognostic value of NLR in other respiratory viral infections, such as Influenza, has not hitherto been extensively studied. We aimed to compare the prognostic value of NLR in COVID-19, Influenza and Respiratory Syncytial Virus infection (RSV). A retrospective cohort of COVID-19, Influenza and RSV patients admitted to the Tel Aviv Medical Center from January 2010 to October 2020 was analyzed. Laboratory, demographic, and clinical parameters were collected. Two way analyses of variance (ANOVA) was used to compare the association between NLR values and poor outcomes among the three groups. ROC curve analyses for each virus was applied to test the discrimination ability of NLR. 722 COVID-19, 2213 influenza and 482 RSV patients were included. Above the age of 50, NLR at admission was significantly lower among COVID-19 patients (P < 0.001). NLR was associated with poor clinical outcome only in the COVID-19 group. ROC curve analysis was performed; the area under curve of poor outcomes for COVID-19 was 0.68, compared with 0.57 and 0.58 for Influenza and RSV respectively. In the COVID-19 group, multivariate logistic regression identified a high NLR (defined as a value above 6.82) to be a prognostic factor for poor clinical outcome, after adjusting for age, sex and Charlson comorbidity score (odds ratio of 2.9, P < 0.001). NLR at admission is lower and has more prognostic value in COVID-19 patients, when compared to Influenza and RSV.
- 2 November 2021
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-8
Open AccessPrognostic value of neutrophil-to-lymphocyte ratio in COVID-19 compared with Influenza and respiratory syncytial virus infection
A high neutrophil to lymphocyte ratio (NLR) is considered an unfavorable prognostic factor in various diseases, including COVID-19. The prognostic value of NLR in other respiratory viral infections, such as Influenza, has not hitherto been extensively studied. We aimed to compare the prognostic value of NLR in COVID-19, Influenza and Respiratory Syncytial Virus infection (RSV). A retrospective cohort of COVID-19, Influenza and RSV patients admitted to the Tel Aviv Medical Center from January 2010 to October 2020 was analyzed. Laboratory, demographic, and clinical parameters were collected. Two way analyses of variance (ANOVA) was used to compare the association between NLR values and poor outcomes among the three groups. ROC curve analyses for each virus was applied to test the discrimination ability of NLR. 722 COVID-19, 2213 influenza and 482 RSV patients were included. Above the age of 50, NLR at admission was significantly lower among COVID-19 patients (P < 0.001). NLR was associated with poor clinical outcome only in the COVID-19 group. ROC curve analysis was performed; the area under curve of poor outcomes for COVID-19 was 0.68, compared with 0.57 and 0.58 for Influenza and RSV respectively. In the COVID-19 group, multivariate logistic regression identified a high NLR (defined as a value above 6.82) to be a prognostic factor for poor clinical outcome, after adjusting for age, sex and Charlson comorbidity score (odds ratio of 2.9, P < 0.001). NLR at admission is lower and has more prognostic value in COVID-19 patients, when compared to Influenza and RSV.
- Open Access
An interactive single cell web portal identifies gene and cell networks in COVID-19 host responses
- 25 May 2021
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 118 (22)
Cross-platform validation of neurotransmitter release impairments in schizophrenia patient-derivedNRXN1-mutant neurons
Significance: HeterozygousNRXN1deletions predispose to schizophrenia and other neurodevelopmental disorders. Engineered heterozygousNRXN1deletions impair neurotransmitter release in human neurons, suggesting a synaptic pathophysiological mechanism. In a multicenter effort to test the generality and robustness of this pivotal observation, we used, at two laboratories, independent analyses of patient-derived and newly engineered human neurons with heterozygousNRXN1deletions. Schizophrenia patient-derived neurons withNRXN1deletions exhibited the same major decrease in neurotransmitter release and an increase in CASK protein as engineered human neurons withNRXN1deletions. Strikingly, engineered mouseNrxn1-deficient neurons derived by the same method displayed no such phenotype, suggesting a human-specific role forNRXN1. Thus, heterozygousNRXN1deletions robustly impair synaptic function in human neurons, enabling future drug discovery efforts.
- 25 May 2021
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 118 (22)
Cross-platform validation of neurotransmitter release impairments in schizophrenia patient-derivedNRXN1-mutant neurons
Significance: HeterozygousNRXN1deletions predispose to schizophrenia and other neurodevelopmental disorders. Engineered heterozygousNRXN1deletions impair neurotransmitter release in human neurons, suggesting a synaptic pathophysiological mechanism. In a multicenter effort to test the generality and robustness of this pivotal observation, we used, at two laboratories, independent analyses of patient-derived and newly engineered human neurons with heterozygousNRXN1deletions. Schizophrenia patient-derived neurons withNRXN1deletions exhibited the same major decrease in neurotransmitter release and an increase in CASK protein as engineered human neurons withNRXN1deletions. Strikingly, engineered mouseNrxn1-deficient neurons derived by the same method displayed no such phenotype, suggesting a human-specific role forNRXN1. Thus, heterozygousNRXN1deletions robustly impair synaptic function in human neurons, enabling future drug discovery efforts.
- Open Access
- 1 January 2021
- Published by Elsevier in SSRN Electronic Journal
Implicating Gene and Cell Networks Responsible for Differential COVID-19 Host Responses via an Interactive Single Cell Web Portal
Numerous studies have provided single-cell transcriptome profiles of host responses to SARS-CoV-2 infection. Critically lacking however is a reusable datamine to allow users to compare and explore these data for insight, inference, and hypothesis generation. To accomplish this, we harmonized datasets from blood, bronchoalveolar lavage and tissue samples from COVID-19 and other control conditions and derived a compendium of gene signature modules per cell type, subtype, clinical condition and compartment. We demonstrate approaches for exploring and evaluating their significance via a new interactive web portal (ToppCell). As examples, we develop three hypotheses: (1) a multicellular signaling cascade among alternatively differentiated monocyte-derived macrophages whose tasks include T cell recruitment and activation; (2) novel platelet subtypes with drastically modulated expression of genes responsible for adhesion, coagulation and thrombosis; (3) a multilineage cell activator network able to drive extrafollicular B maturation via an ensemble of genes extensively associated with risk for developing autoimmunity Funding Information: Funding for this study was provided by LungMap (U24 and HL148865), Digestive Health Center (P30, DK078392) and Harold C. Schott Foundation funding of the Harold C. Schott Endowed Chair, UC College of Medicine. Declaration of Interests: The authors declare no competing interest.
- 1 January 2021
- Published by Elsevier in SSRN Electronic Journal
Open AccessImplicating Gene and Cell Networks Responsible for Differential COVID-19 Host Responses via an Interactive Single Cell Web Portal
Numerous studies have provided single-cell transcriptome profiles of host responses to SARS-CoV-2 infection. Critically lacking however is a reusable datamine to allow users to compare and explore these data for insight, inference, and hypothesis generation. To accomplish this, we harmonized datasets from blood, bronchoalveolar lavage and tissue samples from COVID-19 and other control conditions and derived a compendium of gene signature modules per cell type, subtype, clinical condition and compartment. We demonstrate approaches for exploring and evaluating their significance via a new interactive web portal (ToppCell). As examples, we develop three hypotheses: (1) a multicellular signaling cascade among alternatively differentiated monocyte-derived macrophages whose tasks include T cell recruitment and activation; (2) novel platelet subtypes with drastically modulated expression of genes responsible for adhesion, coagulation and thrombosis; (3) a multilineage cell activator network able to drive extrafollicular B maturation via an ensemble of genes extensively associated with risk for developing autoimmunity Funding Information: Funding for this study was provided by LungMap (U24 and HL148865), Digestive Health Center (P30, DK078392) and Harold C. Schott Foundation funding of the Harold C. Schott Endowed Chair, UC College of Medicine. Declaration of Interests: The authors declare no competing interest.
- Open Access
- 28 January 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-13
Novel Alzheimer’s disease subtypes identified using a data and knowledge driven strategy
The population of adults with Alzheimer’s disease (AD) varies in needs and outcomes. The heterogeneity of current AD diagnostic subgroups impedes the use of data analytics in clinical trial design and translation of findings into improved care. The purpose of this project was to define more clinically-homogeneous groups of AD patients and link clinical characteristics with biological markers. We used an innovative big data analysis strategy, the 3C strategy, that incorporates medical knowledge into the data analysis process. A large set of preprocessed AD Neuroimaging Initiative (ADNI) data was analyzed with 3C. The data analysis yielded 6 new disease subtypes, which differ from the assigned diagnosis types and present different patterns of clinical measures and potential biomarkers. Two of the subtypes, “Anosognosia dementia” and “Insightful dementia”, differentiate between severe participants based on clinical characteristics and biomarkers. The “Uncompensated mild cognitive impairment (MCI)” subtype, demonstrates clinical, demographic and imaging differences from the “Affective MCI” subtype. Differences were also observed between the “Worried Well” and “Healthy” clusters. The use of data-driven analysis yielded sub-phenotypic clinical clusters that go beyond current diagnoses and are associated with biomarkers. Such homogenous sub-groups can potentially form the basis for enhancement of brain medicine research.
- 28 January 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-13
Open AccessNovel Alzheimer’s disease subtypes identified using a data and knowledge driven strategy
The population of adults with Alzheimer’s disease (AD) varies in needs and outcomes. The heterogeneity of current AD diagnostic subgroups impedes the use of data analytics in clinical trial design and translation of findings into improved care. The purpose of this project was to define more clinically-homogeneous groups of AD patients and link clinical characteristics with biological markers. We used an innovative big data analysis strategy, the 3C strategy, that incorporates medical knowledge into the data analysis process. A large set of preprocessed AD Neuroimaging Initiative (ADNI) data was analyzed with 3C. The data analysis yielded 6 new disease subtypes, which differ from the assigned diagnosis types and present different patterns of clinical measures and potential biomarkers. Two of the subtypes, “Anosognosia dementia” and “Insightful dementia”, differentiate between severe participants based on clinical characteristics and biomarkers. The “Uncompensated mild cognitive impairment (MCI)” subtype, demonstrates clinical, demographic and imaging differences from the “Affective MCI” subtype. Differences were also observed between the “Worried Well” and “Healthy” clusters. The use of data-driven analysis yielded sub-phenotypic clinical clusters that go beyond current diagnoses and are associated with biomarkers. Such homogenous sub-groups can potentially form the basis for enhancement of brain medicine research.
- Open Access
- 11 May 2018
- Published by JMIR Publications Inc. in JMIR Medical Informatics
- Vol. 6 (2) , e27-79
The Importance of Nonlinear Transformations Use in Medical Data Analysis
Clinical informatics, decision support for health professionals, electronic health records, and ehealth infrastructures.
- 11 May 2018
- Published by JMIR Publications Inc. in JMIR Medical Informatics
- Vol. 6 (2) , e27-79
Open AccessThe Importance of Nonlinear Transformations Use in Medical Data Analysis
Clinical informatics, decision support for health professionals, electronic health records, and ehealth infrastructures.
- Open Access
- 13 May 2017
- Published by JMIR Publications Inc. in JMIR Preprints
The Importance of Nonlinear Transformations Use in Medical Data Analysis (Preprint)
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: The accumulation of data and its accessibility through easier-to-use platforms will allow data scientists and practitioners who are less sophisticated data analysts to get answers by using big data for many purposes in multiple ways. Data scientists working with medical data are aware of the importance of preprocessing, yet in many cases, the potential benefits of using nonlinear transformations is overlooked. Objective: Our aim is to present a semi-automated approach of symmetry-aiming transformations tailored for medical data analysis and its advantages. Methods: We describe 10 commonly encountered data types used in the medical field and the relevant transformations for each data type. Data from the Alzheimer’s Disease Neuroimaging Initiative study, Parkinson’s disease hospital cohort, and disease-simulating data were used to demonstrate the approach and its benefits. Results: Symmetry-targeted monotone transformations were applied, and the advantages gained in variance, stability, linearity, and clustering are demonstrated. An open source application implementing the described methods was developed. Both linearity of relationships and increase of stability of variability improved after applying proper nonlinear transformation. Clustering simulated nonsymmetric data gave low agreement to the generating clusters (Rand value=0.681), while capturing the original structure after applying nonlinear transformation to symmetry (Rand value=0.986). Conclusions: This work presents the use of nonlinear transformations for medical data and the importance of their semi-automated choice. Using the described approach, the data analyst increases the ability to create simpler, more robust and translational models, thereby facilitating the interpretation and implementation of the analysis by medical practitioners. Applying nonlinear transformations as part of the preprocessing is essential to the quality and interpretability of results.
- 13 May 2017
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessThe Importance of Nonlinear Transformations Use in Medical Data Analysis (Preprint)
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: The accumulation of data and its accessibility through easier-to-use platforms will allow data scientists and practitioners who are less sophisticated data analysts to get answers by using big data for many purposes in multiple ways. Data scientists working with medical data are aware of the importance of preprocessing, yet in many cases, the potential benefits of using nonlinear transformations is overlooked. Objective: Our aim is to present a semi-automated approach of symmetry-aiming transformations tailored for medical data analysis and its advantages. Methods: We describe 10 commonly encountered data types used in the medical field and the relevant transformations for each data type. Data from the Alzheimer’s Disease Neuroimaging Initiative study, Parkinson’s disease hospital cohort, and disease-simulating data were used to demonstrate the approach and its benefits. Results: Symmetry-targeted monotone transformations were applied, and the advantages gained in variance, stability, linearity, and clustering are demonstrated. An open source application implementing the described methods was developed. Both linearity of relationships and increase of stability of variability improved after applying proper nonlinear transformation. Clustering simulated nonsymmetric data gave low agreement to the generating clusters (Rand value=0.681), while capturing the original structure after applying nonlinear transformation to symmetry (Rand value=0.986). Conclusions: This work presents the use of nonlinear transformations for medical data and the importance of their semi-automated choice. Using the described approach, the data analyst increases the ability to create simpler, more robust and translational models, thereby facilitating the interpretation and implementation of the analysis by medical practitioners. Applying nonlinear transformations as part of the preprocessing is essential to the quality and interpretability of results.
- Open Access
- 15 July 2016
- Published by Springer Nature in BioMedical Engineering OnLine
- Vol. 15 (S1) , 21-34
Homogeneous clusters of Alzheimer’s disease patient population
Identification of biomarkers for the Alzheimer’s disease (AD) is a challenge and a very difficult task both for medical research and data analysis. We applied a novel clustering tool with the goal to identify subpopulations of the AD patients that are homogeneous in respect of available clinical as well as in respect of biological descriptors. The main result is identification of three clusters of patients with significant problems with dementia. The evaluation of properties of these clusters demonstrates that brain atrophy is the main driving force of dementia. The unexpected result is that the largest subpopulation that has very significant problems with dementia has besides mild signs of brain atrophy also large ventricular, intracerebral and whole brain volumes. Due to the fact that ventricular enlargement may be a consequence of brain injuries and that a large majority of patients in this subpopulation are males, a potential hypothesis is that such medical status is a consequence of a combination of previous traumatic events and degenerative processes. The results may have substantial consequences for medical research and clinical trial design. The clustering methodology used in this study may be interesting also for other medical and biological domains.
- 15 July 2016
- Published by Springer Nature in BioMedical Engineering OnLine
- Vol. 15 (S1) , 21-34
Open AccessHomogeneous clusters of Alzheimer’s disease patient population
Identification of biomarkers for the Alzheimer’s disease (AD) is a challenge and a very difficult task both for medical research and data analysis. We applied a novel clustering tool with the goal to identify subpopulations of the AD patients that are homogeneous in respect of available clinical as well as in respect of biological descriptors. The main result is identification of three clusters of patients with significant problems with dementia. The evaluation of properties of these clusters demonstrates that brain atrophy is the main driving force of dementia. The unexpected result is that the largest subpopulation that has very significant problems with dementia has besides mild signs of brain atrophy also large ventricular, intracerebral and whole brain volumes. Due to the fact that ventricular enlargement may be a consequence of brain injuries and that a large majority of patients in this subpopulation are males, a potential hypothesis is that such medical status is a consequence of a combination of previous traumatic events and degenerative processes. The results may have substantial consequences for medical research and clinical trial design. The clustering methodology used in this study may be interesting also for other medical and biological domains.